Last updated on April 2020

Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19


Brief description of study

Phase 2:

The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative to the control arm in adult patients hospitalized with COVID-19 regardless of severity strata.

Phase 3:

The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative to the control arm in adult patients hospitalized with COVID-19 (severe and critical).

Clinical Study Identifier: NCT04315298

Find a site near you

Start Over

Regeneron Study Site

Los Angeles, CA United States
6.78miles
  Connect »

Regeneron Study Site

Santa Monica, CA United States
9.31miles
  Connect »